Investor Presentaiton

Successful track record of turning around acquisitions SUN PHARMA ROCE 27% 26% 23% 35% 41% 19% 22% 30% 20% 27% 14% 16% 8% 350 8 Early Acquisitions 4 Acquisitions Recent Acquisitions 300 Assets of: Taro Bryan Dusa 250 Hungary URL Able Labs Ranbaxy 200 150 100 50 FY94 • FY95 FY96 FY97 FY98 FY99 FYOO Sales (Rs Bn) EBITDA (Rs Bn) © Sun Pharmaceutical Industries Limited. All Rights Reserved. Chattem InSite Vision Ocular Tech Odomzo Yonsa FY01 FY02 FY03 FY04 FY05 FY06 FY07 FY08 FY09 FY10 FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 15

View entire presentation